12-03-2025 | Lymphadenectomy | Review Article
Extent of Lymphadenectomy in Intrahepatic Cholangiocarcinoma: Review of Literature
Published in: Indian Journal of Surgical Oncology
Login to get accessPlease log in to get access to this content
Literature
1.
go back to reference Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system. IARC Press, Lyon
Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system. IARC Press, Lyon
2.
go back to reference Nozaki Y, Yamamoto M, Ikai I, Yamamoto Y, Ozaki N, Fujii H et al (1998) Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma. Cancer 83(9):1923–1929. https://doi.org/10.1002/(SICI)1097-0142(19981101)83:9%3c1923::AID-CNCR7%3e3.0.CO;2CrossRefPubMed
Nozaki Y, Yamamoto M, Ikai I, Yamamoto Y, Ozaki N, Fujii H et al (1998) Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma. Cancer 83(9):1923–1929. https://doi.org/10.1002/(SICI)1097-0142(19981101)83:9%3c1923::AID-CNCR7%3e3.0.CO;2CrossRefPubMed
3.
go back to reference Mazzaferro V, Gorgen A, Roayaie S, DrozditBusset M, Sapisochin G (2020) Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 72(2):364–77. https://doi.org/10.1016/j.jhep.2019.11.020CrossRefPubMed
Mazzaferro V, Gorgen A, Roayaie S, DrozditBusset M, Sapisochin G (2020) Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 72(2):364–77. https://doi.org/10.1016/j.jhep.2019.11.020CrossRefPubMed
4.
go back to reference Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D et al (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248(1):84–96. https://doi.org/10.1097/SLA.0b013e318176c4d3CrossRefPubMed
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D et al (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248(1):84–96. https://doi.org/10.1097/SLA.0b013e318176c4d3CrossRefPubMed
5.
go back to reference Rustagi T, Dasanu CA (2012) Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates. J Gastrointest Cancer 43(2):137–147. https://doi.org/10.1007/s12029-011-9284-yCrossRefPubMed
Rustagi T, Dasanu CA (2012) Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates. J Gastrointest Cancer 43(2):137–147. https://doi.org/10.1007/s12029-011-9284-yCrossRefPubMed
6.
go back to reference Sripa B, Pairojkul C (2008) Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 24(3):349–356. https://doi.org/10.1097/MOG.0b013e3282fbf9b3CrossRefPubMedPubMedCentral
Sripa B, Pairojkul C (2008) Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 24(3):349–356. https://doi.org/10.1097/MOG.0b013e3282fbf9b3CrossRefPubMedPubMedCentral
7.
go back to reference Lowenfels AB, Norman J (1978) Isoniazid and bile duct cancer. JAMA 240(4):434–435. https://doi.org/10.1001/jama.1978.03290050024007CrossRefPubMed
Lowenfels AB, Norman J (1978) Isoniazid and bile duct cancer. JAMA 240(4):434–435. https://doi.org/10.1001/jama.1978.03290050024007CrossRefPubMed
8.
go back to reference Wu ZF, Yang N, Li DY, Zhang HB, Yang GS (2013) Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours. J Viral Hepat 20(5):306–310. https://doi.org/10.1111/jvh.12005CrossRefPubMed
Wu ZF, Yang N, Li DY, Zhang HB, Yang GS (2013) Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours. J Viral Hepat 20(5):306–310. https://doi.org/10.1111/jvh.12005CrossRefPubMed
9.
go back to reference Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T et al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60(6):1268–1289. https://doi.org/10.1016/j.jhep.2014.01.021CrossRefPubMed
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T et al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60(6):1268–1289. https://doi.org/10.1016/j.jhep.2014.01.021CrossRefPubMed
10.
go back to reference Weber SM, Ribero D, O’Reilly EM, Kokudo N, Miyazaki M, Pawlik TM (2015) Intrahepatic cholangiocarcinoma: expert consensus statement. HPB 17(8):669–680. https://doi.org/10.1111/hpb.12441CrossRefPubMedPubMedCentral
Weber SM, Ribero D, O’Reilly EM, Kokudo N, Miyazaki M, Pawlik TM (2015) Intrahepatic cholangiocarcinoma: expert consensus statement. HPB 17(8):669–680. https://doi.org/10.1111/hpb.12441CrossRefPubMedPubMedCentral
11.
go back to reference Shirabe K, Shimada M, Harimoto N, Sugimachi K, Yamashita YI, Tsujita E et al (2002) Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 131(3):404–408. https://doi.org/10.1067/msy.2002.119498CrossRef
Shirabe K, Shimada M, Harimoto N, Sugimachi K, Yamashita YI, Tsujita E et al (2002) Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 131(3):404–408. https://doi.org/10.1067/msy.2002.119498CrossRef
12.
go back to reference Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th ed. Springer; 2017
Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th ed. Springer; 2017
13.
go back to reference Lee Y, Yoo IR, Boo SH, Kim H, Park HL, Hyun OJ (2017) The role of F-18 FDG PET/CT in intrahepatic cholangiocarcinoma. Nucl Med Mol Imaging 51(1):69–78. https://doi.org/10.1007/s13139-016-0440-yCrossRefPubMed
Lee Y, Yoo IR, Boo SH, Kim H, Park HL, Hyun OJ (2017) The role of F-18 FDG PET/CT in intrahepatic cholangiocarcinoma. Nucl Med Mol Imaging 51(1):69–78. https://doi.org/10.1007/s13139-016-0440-yCrossRefPubMed
14.
go back to reference Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149(6):565–574. https://doi.org/10.1001/jamasurg.2013.5137CrossRefPubMed
Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149(6):565–574. https://doi.org/10.1001/jamasurg.2013.5137CrossRefPubMed
15.
go back to reference Uenishi T, Kubo S, Yamazaki O, Yamada T, Sasaki Y, Nagano H et al (2008) Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15(4):417–422. https://doi.org/10.1007/s00534-007-1313-7CrossRefPubMed
Uenishi T, Kubo S, Yamazaki O, Yamada T, Sasaki Y, Nagano H et al (2008) Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15(4):417–422. https://doi.org/10.1007/s00534-007-1313-7CrossRefPubMed
16.
go back to reference Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H (2001) Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg 25(10):1257–1263. https://doi.org/10.1007/s00268-001-0107-3CrossRef
Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H (2001) Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg 25(10):1257–1263. https://doi.org/10.1007/s00268-001-0107-3CrossRef
17.
go back to reference Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Giulini SM et al (2007) Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg 142(3):269–275. https://doi.org/10.1001/archsurg.142.3.269CrossRef
Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Giulini SM et al (2007) Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg 142(3):269–275. https://doi.org/10.1001/archsurg.142.3.269CrossRef
18.
go back to reference Zhou R, Lu D, Li W, Tan W, Zhu S, Chen X et al (2019) Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A Syst Rev Meta-Anal HPB 21(6):784–792. https://doi.org/10.1016/j.hpb.2018.12.011CrossRef
Zhou R, Lu D, Li W, Tan W, Zhu S, Chen X et al (2019) Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A Syst Rev Meta-Anal HPB 21(6):784–792. https://doi.org/10.1016/j.hpb.2018.12.011CrossRef
19.
go back to reference Vitale A, Moustafa M, Spolverato G, Gani F, Cillo U, Pawlik TM (2016) Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma. J Surg Oncol 113(7):685–691. https://doi.org/10.1002/jso.24213CrossRefPubMed
Vitale A, Moustafa M, Spolverato G, Gani F, Cillo U, Pawlik TM (2016) Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma. J Surg Oncol 113(7):685–691. https://doi.org/10.1002/jso.24213CrossRefPubMed
20.
go back to reference Kim SH, Han DH, Choi GH, Choi JS, Kim KS (2019) Oncologic impact of lymph node dissection for intrahepatic cholangiocarcinoma: a propensity score-matched study. J Gastrointest Surg 23(4):538–544. https://doi.org/10.1007/s11605-018-3899-2CrossRefPubMed
Kim SH, Han DH, Choi GH, Choi JS, Kim KS (2019) Oncologic impact of lymph node dissection for intrahepatic cholangiocarcinoma: a propensity score-matched study. J Gastrointest Surg 23(4):538–544. https://doi.org/10.1007/s11605-018-3899-2CrossRefPubMed
21.
go back to reference Huang S, Song JL, Li B, Yi PS, Yang J (2023) Should lymphadenectomy be performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis. BMC Surg 23(1):29. https://doi.org/10.1186/s12893-023-02255-5CrossRef
Huang S, Song JL, Li B, Yi PS, Yang J (2023) Should lymphadenectomy be performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis. BMC Surg 23(1):29. https://doi.org/10.1186/s12893-023-02255-5CrossRef
22.
go back to reference Yang F, Wu C, Bo Z, Xu J, Yi B, Li J et al (2022) The clinical value of regional lymphadenectomy for intrahepatic cholangiocarcinoma. Asian J Surg 45(2):376–380. https://doi.org/10.1016/j.asjsur.2021.06.031CrossRefPubMed
Yang F, Wu C, Bo Z, Xu J, Yi B, Li J et al (2022) The clinical value of regional lymphadenectomy for intrahepatic cholangiocarcinoma. Asian J Surg 45(2):376–380. https://doi.org/10.1016/j.asjsur.2021.06.031CrossRefPubMed
23.
go back to reference Yoh T, Cauchy F, Le Roy B, Seo S, Taura K, Hobeika C et al (2019) Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: a multicenter study. Surgery 166(5):975–982. https://doi.org/10.1016/j.surg.2019.06.025CrossRefPubMed
Yoh T, Cauchy F, Le Roy B, Seo S, Taura K, Hobeika C et al (2019) Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: a multicenter study. Surgery 166(5):975–982. https://doi.org/10.1016/j.surg.2019.06.025CrossRefPubMed
24.
go back to reference Bagante F, Spolverato G, Weiss M, Alexandrescu S, Marques HP, Aldrighetti L et al (2018) Surgical management of intrahepatic cholangiocarcinoma in patients with cirrhosis: impact of lymphadenectomy on peri-operative outcomes. World J Surg 42(12):2551–2560. https://doi.org/10.1007/s00268-017-4453-1CrossRefPubMed
Bagante F, Spolverato G, Weiss M, Alexandrescu S, Marques HP, Aldrighetti L et al (2018) Surgical management of intrahepatic cholangiocarcinoma in patients with cirrhosis: impact of lymphadenectomy on peri-operative outcomes. World J Surg 42(12):2551–2560. https://doi.org/10.1007/s00268-017-4453-1CrossRefPubMed
25.
go back to reference Miyata T, Yamashita YI, Yamao T, Umezaki N, Tsukamoto M, Kitano Y et al (2017) Clinical benefits of lymph node dissection in intrahepatic cholangiocarcinoma: a retrospective single-institution study. Anticancer Res 37(5):2673–2677. https://doi.org/10.21873/anticanres.11615CrossRefPubMed
Miyata T, Yamashita YI, Yamao T, Umezaki N, Tsukamoto M, Kitano Y et al (2017) Clinical benefits of lymph node dissection in intrahepatic cholangiocarcinoma: a retrospective single-institution study. Anticancer Res 37(5):2673–2677. https://doi.org/10.21873/anticanres.11615CrossRefPubMed
26.
go back to reference Chang ME, Lei HJ, Chen MH, Yeh YC, Li CP, Hung YP et al (2017) Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center. J Chin Med Assoc 80(2):140–146. https://doi.org/10.1016/j.jcma.2016.09.010CrossRefPubMed
Chang ME, Lei HJ, Chen MH, Yeh YC, Li CP, Hung YP et al (2017) Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center. J Chin Med Assoc 80(2):140–146. https://doi.org/10.1016/j.jcma.2016.09.010CrossRefPubMed
27.
go back to reference Morine Y, Shimada M (2015) The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol 50(9):913–927. https://doi.org/10.1007/s00535-015-1071-2CrossRefPubMed
Morine Y, Shimada M (2015) The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol 50(9):913–927. https://doi.org/10.1007/s00535-015-1071-2CrossRefPubMed
28.
go back to reference Wu ZF, Wu XY, Zhu N, Xu Z, Li WS, Zhang HB et al (2015) Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 21(3):935–943. https://doi.org/10.3748/wjg.v21.i3.935CrossRefPubMedPubMedCentral
Wu ZF, Wu XY, Zhu N, Xu Z, Li WS, Zhang HB et al (2015) Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 21(3):935–943. https://doi.org/10.3748/wjg.v21.i3.935CrossRefPubMedPubMedCentral
29.
go back to reference Kim DH, Choi DW, Choi SH, Heo JS, Kow AWC (2015) Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution. Surgery 157(4):666–675. https://doi.org/10.1016/j.surg.2014.11.006CrossRefPubMed
Kim DH, Choi DW, Choi SH, Heo JS, Kow AWC (2015) Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution. Surgery 157(4):666–675. https://doi.org/10.1016/j.surg.2014.11.006CrossRefPubMed
30.
go back to reference Li DY, Zhang HB, Yang N, Quan Y, Yang GS (2013) Routine lymph node dissection may not be suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series. World J Gastroenterol 19(47):9084–9091. https://doi.org/10.3748/wjg.v19.i47.9084CrossRefPubMedPubMedCentral
Li DY, Zhang HB, Yang N, Quan Y, Yang GS (2013) Routine lymph node dissection may not be suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series. World J Gastroenterol 19(47):9084–9091. https://doi.org/10.3748/wjg.v19.i47.9084CrossRefPubMedPubMedCentral
31.
go back to reference Morine Y, Shimada M, Utsunomiya T, Imura S, Ikemoto T, Mori H et al (2012) Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today 42(2):147–151. https://doi.org/10.1007/s00595-011-0057-9CrossRefPubMed
Morine Y, Shimada M, Utsunomiya T, Imura S, Ikemoto T, Mori H et al (2012) Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today 42(2):147–151. https://doi.org/10.1007/s00595-011-0057-9CrossRefPubMed
32.
go back to reference Fisher SB, Patel SH, Kooby DA, Weber S, Bloomston M, Cho C et al (2012) Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis. HPB (Oxford) 14(8):514–522. https://doi.org/10.1111/j.1477-2574.2012.00489.xCrossRefPubMed
Fisher SB, Patel SH, Kooby DA, Weber S, Bloomston M, Cho C et al (2012) Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis. HPB (Oxford) 14(8):514–522. https://doi.org/10.1111/j.1477-2574.2012.00489.xCrossRefPubMed
33.
go back to reference Nuzzo G, Giuliante F, Ardito F, De Rose AM, Vellone M, Clemente G et al (2010) Intrahepatic cholangiocarcinoma: prognostic factors after liver resection. Updates Surg 62(1):11–19. https://doi.org/10.1007/s13304-010-0007-xCrossRefPubMed
Nuzzo G, Giuliante F, Ardito F, De Rose AM, Vellone M, Clemente G et al (2010) Intrahepatic cholangiocarcinoma: prognostic factors after liver resection. Updates Surg 62(1):11–19. https://doi.org/10.1007/s13304-010-0007-xCrossRefPubMed
34.
go back to reference Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T et al (2009) Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 145(4):411–416. https://doi.org/10.1016/j.surg.2008.11.010CrossRefPubMed
Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T et al (2009) Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 145(4):411–416. https://doi.org/10.1016/j.surg.2008.11.010CrossRefPubMed
35.
go back to reference Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ et al (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16(9):3048–3056. https://doi.org/10.1245/s10434-009-0631-1CrossRefPubMed
Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ et al (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16(9):3048–3056. https://doi.org/10.1245/s10434-009-0631-1CrossRefPubMed
36.
go back to reference Pawlik TM (2019) ASO author reflections: routine lymphadenectomy should be recommended regardless of morphologic subtype of intrahepatic cholangiocarcinoma. Ann Surg Oncol 26(7):2251–2252. https://doi.org/10.1245/s10434-019-07438-0CrossRefPubMed
Pawlik TM (2019) ASO author reflections: routine lymphadenectomy should be recommended regardless of morphologic subtype of intrahepatic cholangiocarcinoma. Ann Surg Oncol 26(7):2251–2252. https://doi.org/10.1245/s10434-019-07438-0CrossRefPubMed
37.
go back to reference Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D et al (2016) Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis treatment and follow-up. Ann Oncol 27(suppl_5):v28–v37. https://doi.org/10.1093/annonc/mdw324CrossRefPubMed
Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D et al (2016) Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis treatment and follow-up. Ann Oncol 27(suppl_5):v28–v37. https://doi.org/10.1093/annonc/mdw324CrossRefPubMed
38.
go back to reference Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA et al (2017) NCCN guidelines insights: hepatobiliary cancers version 1.2017. J Natl Compr Canc Netw 5(5):563–73. https://doi.org/10.6004/jnccn.2017.0059CrossRef
Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA et al (2017) NCCN guidelines insights: hepatobiliary cancers version 1.2017. J Natl Compr Canc Netw 5(5):563–73. https://doi.org/10.6004/jnccn.2017.0059CrossRef
39.
go back to reference Franken LC, Coelen RJS, Roos E, Verheij J, Phoa SS, Besselink MG et al (2020) Staging laparoscopy in patients with intrahepatic cholangiocarcinoma: is it still useful? Visc Med 36(6):501–505. https://doi.org/10.1159/000506297CrossRefPubMedPubMedCentral
Franken LC, Coelen RJS, Roos E, Verheij J, Phoa SS, Besselink MG et al (2020) Staging laparoscopy in patients with intrahepatic cholangiocarcinoma: is it still useful? Visc Med 36(6):501–505. https://doi.org/10.1159/000506297CrossRefPubMedPubMedCentral
40.
go back to reference Weber SM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR (2002) Staging laparoscopy in patients with extrahepatic biliary carcinoma: analysis of 100 patients. Ann Surg 235(3):392–399. https://doi.org/10.1097/00000658-200203000-00011CrossRefPubMedPubMedCentral
Weber SM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR (2002) Staging laparoscopy in patients with extrahepatic biliary carcinoma: analysis of 100 patients. Ann Surg 235(3):392–399. https://doi.org/10.1097/00000658-200203000-00011CrossRefPubMedPubMedCentral
41.
go back to reference D’Angelica M, Fong Y, Weber S, Gonen M, DeMatteo RP, Conlon K et al (2003) The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol 10(2):183–189. https://doi.org/10.1245/aso.2003.03.095CrossRefPubMed
D’Angelica M, Fong Y, Weber S, Gonen M, DeMatteo RP, Conlon K et al (2003) The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol 10(2):183–189. https://doi.org/10.1245/aso.2003.03.095CrossRefPubMed
42.
go back to reference Coletta D, Scarinci A, Grazi GL, Patriti A (2023) The role of staging laparoscopy for intrahepatic cholangiocarcinoma: a snapshot of the current literature. J Laparoendosc Adv Surg Tech A 33(9):1019–1024. https://doi.org/10.1089/lap.2023.0193CrossRefPubMed
Coletta D, Scarinci A, Grazi GL, Patriti A (2023) The role of staging laparoscopy for intrahepatic cholangiocarcinoma: a snapshot of the current literature. J Laparoendosc Adv Surg Tech A 33(9):1019–1024. https://doi.org/10.1089/lap.2023.0193CrossRefPubMed
43.
go back to reference Yoh T, Hatano E, Seo S, Terajima H, Uchida Y, Taura K et al (2018) Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 25(4):299–307. https://doi.org/10.1002/jhbp.552CrossRefPubMed
Yoh T, Hatano E, Seo S, Terajima H, Uchida Y, Taura K et al (2018) Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 25(4):299–307. https://doi.org/10.1002/jhbp.552CrossRefPubMed
Metadata
- Title
- Extent of Lymphadenectomy in Intrahepatic Cholangiocarcinoma: Review of Literature
- Authors
-
Amit Gupta
Rohik Anjum T. Siddeek
Rahul Kumar
Ritu Thakur
Vivek Sanjekar
Nirbhay Kumar Bind
Ajit Kumar
- Publication date
- 12-03-2025
- Publisher
- Springer India
- Published in
-
Indian Journal of Surgical Oncology
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952 - DOI
- https://doi.org/10.1007/s13193-025-02273-0
Image Credits
Chronic pancreatitis 3D concept image/© Rasi Bhadramani